UPLC–ESI-Q-TOF-MSE identification of urinary metabolites of the emerging sport nutrition supplement methoxyisoflavone in human subjects

2014 ◽  
Vol 96 ◽  
pp. 127-134 ◽  
Author(s):  
Yannick Lecompte ◽  
Martine Rosset ◽  
Camille Richeval ◽  
Luc Humbert ◽  
Patrick Arpino
1968 ◽  
Vol 42 (2) ◽  
pp. 337-343 ◽  
Author(s):  
SORAYA KAMYAB ◽  
K. FOTHERBY ◽  
A. I. KLOPPER

SUMMARY After the administration of [4-14C]lynestrenol (17α-ethynyl-19-nor-androst-4-en-17β-ol) to 7 human subjects 31·–57·6% of the dose, whether administered orally or i.v., was excreted in the urine within 5 days. The biological half-life of radioactivity was 26·5 hr. After acid and enzymatic hydrolysis, 58·7 and 45·6% respectively of the urinary radioactivity was extractable. About 10% of the urinary metabolites were excreted as sulphate conjugates. A mean value of 1·75% of the administered dose was converted to phenolic compounds. The metabolites in the free fraction and enzymehydrolysed extract of urine were almost entirely polar compounds, whereas 70% of the metabolites in the sulphate fraction were much less polar. The chromatographic evidence showed that hydroxylation of lynestrenol must have occurred at two points in the molecule. Plasma radioactivity decreased more rapidly than after administration of norethisterone.


1968 ◽  
Vol 41 (2) ◽  
pp. 263-272 ◽  
Author(s):  
SORAYA KAMYAB ◽  
K. FOTHERBY ◽  
A. I. KLOPPER

SUMMARY After the administration of norethisterone to seven human subjects 37·4% to 80·6% of the dose was excreted in the urine within 5 days. About half of the urinary radioactivity was extractable after acid or enzymatic hydrolysis and about 80% was extracted by using a serial hydrolytic and extraction procedure. About 15% of the urinary radioactivity was present as sulphate conjugates. About 5% of the urinary radioactivity was present in acidic or phenolic compounds. No metabolism of the ethynyl group seemed to occur and the Girard reaction showed that about half of the urinary metabolites were ketonic. The metabolites in the glucuronide fraction of urine were predominantly more polar on paper chromatography than tetrahydronorethisterone, whereas in the sulphate fraction most of the metabolites had a polarity similar to the simple reduction products of norethisterone. Two days after injection the plasma still contained about 5% of the administered dose.


1985 ◽  
Vol 231 (2) ◽  
pp. 481-484 ◽  
Author(s):  
N J Manning ◽  
R J Pollitt

Two human subjects were given separate oral doses of sodium [2H6]isobutyrate and [methyl-2H3]thymine and the labelling patterns of urinary metabolites were determined. Ingestion of deuterated isobutyrate resulted in the excretion of 2H5-labelled S-3-hydroxyisobutyric acid, formed on the direct catabolic pathway, and of S- and R-[2H4]-3-hydroxyisobutyric acids, formed by the reduction of S- and R-methylmalonic semialdehydes respectively. Only the R-enantiomer of urinary 3-hydroxyisobutyric acid was labelled by thymine. This labelling pattern indicates a flow from S- to R-methylmalonic semialdehyde, suggesting that the R-enantiomer is the substrate of methylmalonic semialdehyde dehydrogenase.


1960 ◽  
Vol 20 (12) ◽  
pp. 1568-1575 ◽  
Author(s):  
EDWARD CHANG ◽  
W. ROY SLAUNWHITE ◽  
AVERY A. SANDBERG

2004 ◽  
Vol 52 (22) ◽  
pp. 6802-6809 ◽  
Author(s):  
Satu-Maarit Heinonen ◽  
Kristiina Wähälä ◽  
Herman Adlercreutz

2019 ◽  
Vol 9 (5) ◽  
pp. 879 ◽  
Author(s):  
Chien-Che Hung ◽  
Sailent Simaremare ◽  
Chia-Jung Hsieh ◽  
Lih-Ming Yiin

We have developed a rapid, sensitive, and reliable method for simultaneous determination of the urinary metabolites of common insecticides in a single analytical run using gas chromatography–mass spectrometry (GCMS). Thirteen metabolites, one originating from carbamate, six from organophosphates, and seven from pyrethroids, were selected for method validation. Samples at different concentrations (0.5–15 µg/L) were prepared by mixing working solutions containing the analytes with blank urine. After acid hydrolysis for 45 min at 90 °C, samples were processed with liquid–liquid extraction and derivatization by N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) before analysis on GCMS. The limits of detection for all thirteen analytes were below 0.1 µg/L. The recovery rates, evaluated at two concentrations (1, 10 µg/L), were found to be 90.48%, on average. The precision of multiple analyses at three different concentrations (0.5, 5, 15 µg/L) within one day or between 10 days was evaluated, and the resultant relative standard deviations were 8.1% or under. We also applied this method to analyze genuine urine samples collected from 30 human subjects, and successfully detected all the metabolites, with detection frequencies more than 50% for pyrethroid metabolites. In summary, this method is not only as good as others in performance, but is advantageous in terms of cost effectiveness and multiplicity of analytes.


1993 ◽  
Vol 69 (03) ◽  
pp. 276-281 ◽  
Author(s):  
H Morio ◽  
A Hirai ◽  
T Terano ◽  
Y Tamura ◽  
S Yoshida

SummaryThe influence of OKY-046, a selective thromboxane synthase inhibitor, on prostanoid formation in healthy human subjects was studied. Vehicle (5% glucose solution) or OKY-046 in 5% glucose solution at 15 μg kg−1 min−1 was intravenously administered to five male healthy volunteers for 6 h. Platelet aggregation and thromboxane B2 (TXB2) formation induced by collagen and arachidonic acid were suppressed by the infusion of OKY-046, while both were not affected by the infusion of vehicle. Urinary excretion of 11-dehydro-thromboxane B2, one of major urinary metabolites of thromboxane A2 (TXA2) was decreased by the infusion of OKY-046, while that of 2,3-dinor-6-keto-prostaglandin F1α, one of major urinary metabolites of prostacyclin (PGI2) was increased. The present study demonstrated that the infusion of OKY-046 improved the balance of TXA2/PGI2 into antithrombotic state in healthy subjects. It was also suggested that endogenously produced (probably platelet-derived) endoperoxides could be redirected into prostacyclin in vivo.


1961 ◽  
Vol 21 (12) ◽  
pp. 1534-1542 ◽  
Author(s):  
A. VERMEULEN ◽  
W. R. SLAUNWHITE ◽  
AVERYA. SAXDBERG

1999 ◽  
Vol 9 (1) ◽  
pp. 70-88 ◽  
Author(s):  
Sheila A. Kopp-Woodroffe ◽  
Melinda M. Manore ◽  
Christine A. Dueck ◽  
James S. Skinner ◽  
Kathleen S. Matt

Chronic energy deficit is one of the strongest factors contributing to exercise-induced menstrual dysfunction. In such cases, macro- and micronutrient intakes may also be low. This study presents the results of a diet and exercise training intervention program, designed to reverse athletic amenorrhea, on improving energy balance and nutritional status in 4 amenorrheic athletes. The 20-week program provided a daily sport nutrition supplement and 1 day of rest/week. The intervention improved self-reported energy intake (El) and balance in all participants. The program increased protein intakes for the 3 athletes with a protein deficit to within the recommended levels for active individuals. Micronutrient intakes increased, as did serum concentrations of vitamin B12, folate, zinc, iron, and ferritin. These results indicate that some amenorrheic athletes have poor nutritional status due to restricted Els and poor food selections. A sport nutrition supplement may improve energy balance and nutritional status in active amenorrheic women.


Sign in / Sign up

Export Citation Format

Share Document